AU5213300A - 2-nh-pyridones and pyrimidones as mrs inhibitors - Google Patents

2-nh-pyridones and pyrimidones as mrs inhibitors

Info

Publication number
AU5213300A
AU5213300A AU52133/00A AU5213300A AU5213300A AU 5213300 A AU5213300 A AU 5213300A AU 52133/00 A AU52133/00 A AU 52133/00A AU 5213300 A AU5213300 A AU 5213300A AU 5213300 A AU5213300 A AU 5213300A
Authority
AU
Australia
Prior art keywords
pyrimidones
pyridones
mrs
inhibitors
mrs inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52133/00A
Inventor
Sula Anne Armstrong
John Michael Berge
Pamela Brown
John Stephen Elder
Andrew Keith Forrest
Dieter Wolfgang Hamprecht
Richard Lewis Jarvest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9911595.8A external-priority patent/GB9911595D0/en
Priority claimed from GBGB9911596.6A external-priority patent/GB9911596D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU5213300A publication Critical patent/AU5213300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU52133/00A 1999-05-19 2000-05-16 2-nh-pyridones and pyrimidones as mrs inhibitors Abandoned AU5213300A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9911595 1999-05-19
GBGB9911595.8A GB9911595D0 (en) 1999-05-19 1999-05-19 Novel compounds
GBGB9911596.6A GB9911596D0 (en) 1999-05-19 1999-05-19 Novel compounds
GB9911596 1999-05-19
PCT/EP2000/004436 WO2000071524A1 (en) 1999-05-19 2000-05-16 2-nh-pyridones and pyrimidones as mrs inhibitors

Publications (1)

Publication Number Publication Date
AU5213300A true AU5213300A (en) 2000-12-12

Family

ID=26315562

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52133/00A Abandoned AU5213300A (en) 1999-05-19 2000-05-16 2-nh-pyridones and pyrimidones as mrs inhibitors

Country Status (3)

Country Link
JP (1) JP2003500397A (en)
AU (1) AU5213300A (en)
WO (1) WO2000071524A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005504807A (en) 2001-09-26 2005-02-17 バイエル・フアーマシユーチカルズ・コーポレーシヨン 1,8-naphthyridine derivatives as antidiabetic agents
EP1603881A4 (en) 2003-03-03 2010-07-07 Replidyne Inc Substituted thiophenes with antibacterial activity
GB0304809D0 (en) 2003-03-03 2003-04-09 Glaxo Group Ltd Novel compounds
JP2007502861A (en) * 2003-05-01 2007-02-15 レプリダイン・インコーポレーテッド Antibacterial methods and compositions
WO2008039642A2 (en) 2006-09-26 2008-04-03 Replidyne, Inc. Methods and compounds for treatment of clostridium based infection
US7973050B2 (en) * 2006-09-26 2011-07-05 Crestone, Inc. Enantiomeric compounds with antibacterial activity
US8697720B2 (en) * 2006-09-26 2014-04-15 Crestone, Inc. Substituted phenylether-thienopyridone compounds with antibacterial activity
US7994192B2 (en) * 2006-09-26 2011-08-09 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
US7928111B2 (en) * 2007-06-08 2011-04-19 Senomyx, Inc. Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
US9603848B2 (en) 2007-06-08 2017-03-28 Senomyx, Inc. Modulation of chemosensory receptors and ligands associated therewith
WO2010014666A2 (en) 2008-07-31 2010-02-04 Senomyx, Inc. Processes and intermediates for making sweet taste enhancers
DE102011009961A1 (en) 2011-02-01 2012-08-02 Merck Patent Gmbh 7-azaindole derivatives
PE20191204A1 (en) 2012-08-06 2019-09-10 Firmenich Incorporated SWEET FLAVOR MODIFIER
JO3155B1 (en) 2013-02-19 2017-09-20 Senomyx Inc Sweet flavor modifier
WO2020033420A1 (en) 2018-08-07 2020-02-13 Firmenich Incorporated 5-substituted 4-amino-1h-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601264A1 (en) * 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellated thienyl and furanyl oxazolidinones
PL343680A1 (en) * 1998-04-29 2001-08-27 Smithkline Beecham Plc Quinolones used as mrs inhibitors and bactericides
GB9822241D0 (en) * 1998-10-12 1998-12-09 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
JP2003500397A (en) 2003-01-07
WO2000071524A1 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
AU5991699A (en) Quinolizinones as integrin inhibitors
AUPQ419099A0 (en) Novel compositions and methods
HK1044545A1 (en) Human beta-secretase enzyme, inhibitors and their compositions and uses
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU5213300A (en) 2-nh-pyridones and pyrimidones as mrs inhibitors
AU9059798A (en) Urokinase inhibitors
AU1403501A (en) Novel composition and use
AU2002211662A1 (en) Nf-kappab inhibitors
AU2001286242A1 (en) Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
AU2001276027A1 (en) Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
PL353214A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
AU7961300A (en) Kainic acid neurocytotoxicity inhibitors
AU7126900A (en) Enzyme inhibitors
AU2001263270A1 (en) Imaging-offset compensation methods and systems
AU2002216650A1 (en) Triazine derivatives as lpaat-b inhibitors and uses thereof
AU3235100A (en) Prothease inhibitors
GB9924522D0 (en) Enzyme inhibitors
AU3761400A (en) Amino-thio-acrylonitriles as mek inhibitors
AU2001277561A1 (en) Biphenyl derivatives and the use thereof as integrin inhibitors
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU7127000A (en) Enzyme inhibitors
AU3595900A (en) Tyrosine alkoxyguanidines as integrin inhibitors
AU5571799A (en) Angiogenesis inhibitors and uses thereof
AU2876000A (en) Tyrosine kinase inhibitors and methods of using the same
AU7127100A (en) Enzyme inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase